Georgetown University Lombardi Cancer Center Support Grant View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

1990-2019

FUNDING AMOUNT

49939224 USD

ABSTRACT

The mission of the Georgetown Lombardi Comprehensive Cancer Center (LCCC) is to prevent, treat and cure cancers by linking scientific discovery, expert and compassionate patient care, quality education, and partnership with the community, guided by the principle of cura personalis (care for the whole person). LCCC is led by Director Louis M. Weiner, MD, a medical oncologist and immunotherapy expert, with the support of Deputy Director Michael B. Atkins, MD, six Associate Directors (ADs) and Sandra M. Swain, LCCC's clinical network representative. Four Research Programs?Breast Cancer, Cancer Prevention and Control, Experimental Therapeutics and Molecular Oncology?conduct high-impact studies supported by nine Shared Resources. LCCC has 91 members, with a current annual total of $28.7M in peer-reviewed ($18.5M NCI) cancer-focused funding (direct costs), resulting in 1,100 peer-reviewed cancer-related publications from 2009-2012; 32% of which involved intra- and/or interprogrammatic collaborations, and 53% of which involved external collaborations. In 2012, LCCC placed 244 patients on interventional clinical trials (13% of new patients). Notable accomplishments include: 1) discovery of a transformative methodology for epithelial cell reprogramming with rapid translation into clinical trials; 2) development of enabling tools such as novel computational modeling for drug repurposing and integrated informatic platforms; 3) basic discovery (novel mechanisms for genomic instability; transcriptional targeting in Ewing sarcoma; resistance determinants in the EGFR network); 4) leadership of high-impact clinical trials (e.g., evaluation of pertuzumab in breast cancer, role of bendamustine in follicular lymphoma); 5) national collaborative modeling research informing screening mammography guidelines and 6) operational enhancements that include creation of the MedStar Georgetown Cancer Network to expand clinical research in LCCC's catchment area under the direction of recent recruit, Giuseppe Giaccone, MD, PhD (AD, Clinical Research); a reorganization of clinical trial management and regulatory activities to better support the Network; and the continued development of community outreach and research sites in the poorest wards of the District of Columbia. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=9483614

Related SciGraph Publications

  • 2019-12. Shared heritability and functional enrichment across six solid cancers in NATURE COMMUNICATIONS
  • 2019-03-09. Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study in BREAST CANCER RESEARCH AND TREATMENT
  • 2019-02. Development of a Human APOE Knock-in Mouse Model for Study of Cognitive Function After Cancer Chemotherapy in NEUROTOXICITY RESEARCH
  • 2019-01-07. The complex entanglement of Hippo-Yap/Taz signaling in tumor immunity in ONCOGENE
  • 2018-12. Investigating molecular interactions between oxidized neuroglobin and cytochrome c in SCIENTIFIC REPORTS
  • 2018-12. Modulation of nuclear factor-kappa B activation by the endoplasmic reticulum stress sensor PERK to mediate estrogen-induced apoptosis in breast cancer cells in CELL DEATH DISCOVERY
  • 2018-12. Plac1 Is a Key Regulator of the Inflammatory Response and Immune Tolerance In Mammary Tumorigenesis in SCIENTIFIC REPORTS
  • 2018-12. Plasma microRNA markers of upper limb recovery following human stroke in SCIENTIFIC REPORTS
  • 2018-12. Paternal malnutrition programs breast cancer risk and tumor metabolism in offspring in BREAST CANCER RESEARCH
  • 2018-12. Human ex vivo 3D bone model recapitulates osteocyte response to metastatic prostate cancer in SCIENTIFIC REPORTS
  • 2018-09. High-risk acute promyelocytic leukemia with unusual T/myeloid immunophenotype successfully treated with ATRA and arsenic trioxide-based regimen in JOURNAL OF HEMATOPATHOLOGY
  • 2018-08. Hydrophilic interaction liquid chromatography in the separation of glycopeptides and their isomers in ANALYTICAL AND BIOANALYTICAL CHEMISTRY
  • 2018-08. Developing a Mass Media Campaign to Promote Mammography Awareness in African American Women in the Nation’s Capital in JOURNAL OF COMMUNITY HEALTH
  • 2018-08. Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients in BREAST CANCER RESEARCH AND TREATMENT
  • 2018-08. Relationship between sleep and exercise as colorectal cancer survivors transition off treatment in SUPPORTIVE CARE IN CANCER
  • 2018-07. The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer in CELL DEATH & DIFFERENTIATION
  • 2018-07. Information and support needs of young women regarding breast cancer risk and genetic testing: adapting effective interventions for a novel population in FAMILIAL CANCER
  • 2018-06. PCB exposure and potential future cancer incidence in Slovak children: an assessment from molecular finger printing by Ingenuity Pathway Analysis (IPA®) derived from experimental and epidemiological investigations in ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
  • 2018-05. The PPARγ agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ in BREAST CANCER RESEARCH AND TREATMENT
  • 2018-02. Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2017-12. Video intervention increases participation of black breast cancer patients in therapeutic trials in NPJ BREAST CANCER
  • 2017-12. HPV positive neuroendocrine cervical cancer cells are dependent on Myc but not E6/E7 viral oncogenes in SCIENTIFIC REPORTS
  • 2017-12. Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutations in SCIENTIFIC REPORTS
  • 2017-12. An unbiased in vivo functional genomics screening approach in mice identifies novel tumor cell-based regulators of immune rejection in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2017-12. Circulating microRNAs in patients with hormone receptor-positive, metastatic breast cancer treated with dovitinib in CLINICAL AND TRANSLATIONAL MEDICINE
  • 2017-12. Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis in SCIENTIFIC REPORTS
  • 2017-10. Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance) in BREAST CANCER RESEARCH AND TREATMENT
  • 2017-06. The effects of framed messages for engaging adolescents with online smoking prevention interventions in TRANSLATIONAL BEHAVIORAL MEDICINE
  • 2017-05. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer in NATURE GENETICS
  • 2017-04. Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers in EUROPEAN JOURNAL OF HUMAN GENETICS
  • 2017-03. Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma in ONCOGENE
  • 2017-02. Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion in ONCOGENE
  • 2017-02. The Role of Knowledge on Genetic Counseling and Testing in Black Cancer Survivors at Increased Risk of Carrying a BRCA1/2 Mutation in JOURNAL OF GENETIC COUNSELING
  • 2017. Fluorescence In Situ Hybridization of Cells, Chromosomes, and Formalin-Fixed Paraffin-Embedded Tissues in MOLECULAR PROFILING
  • 2017-01. Site-specific analysis of changes in the glycosylation of proteins in liver cirrhosis using data-independent workflow with soft fragmentation in ANALYTICAL AND BIOANALYTICAL CHEMISTRY
  • 2016-10. Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth in CELL DEATH & DIFFERENTIATION
  • 2016-09-07. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus in NATURE COMMUNICATIONS
  • 2016-09. Paternal overweight is associated with increased breast cancer risk in daughters in a mouse model in SCIENTIFIC REPORTS
  • 2016-06. Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic Counseling in JOURNAL OF GENETIC COUNSELING
  • 2016-05. A lipidomic and metabolomic serum signature from nonhuman primates exposed to ionizing radiation in METABOLOMICS
  • 2016-03. Patient preference and decision-making for initiating metastatic colorectal cancer medical treatment in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2016-01. Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines in BREAST CANCER RESEARCH AND TREATMENT
  • 2015-12. Reactivation of latent HIV-1 provirus via targeting protein phosphatase-1 in RETROVIROLOGY
  • 2015-12. Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2015-12. Radiation therapy at the end of life: a population-based study examining palliative treatment intensity in RADIATION ONCOLOGY
  • 2015-12. ERRγ target genes are poor prognostic factors in Tamoxifen-treated breast cancer in JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
  • 2015-12. Distinct serum metabolomics profiles associated with malignant progression in the KrasG12Dmouse model of pancreatic ductal adenocarcinoma in BMC GENOMICS
  • 2015-11. Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling in ONCOGENE
  • 2015-10. Baseline Attitudes About Prostate Cancer Screening Moderate the Impact of Decision Aids on Screening Rates in ANNALS OF BEHAVIORAL MEDICINE
  • 2015-10. Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients in QUALITY OF LIFE RESEARCH
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2211", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "amount": {
          "currency": "USD", 
          "type": "MonetaryAmount", 
          "value": "49939224"
        }, 
        "description": "The mission of the Georgetown Lombardi Comprehensive Cancer Center (LCCC) is to prevent, treat and cure cancers by linking scientific discovery, expert and compassionate patient care, quality education, and partnership with the community, guided by the principle of cura personalis (care for the whole person). LCCC is led by Director Louis M. Weiner, MD, a medical oncologist and immunotherapy expert, with the support of Deputy Director Michael B. Atkins, MD, six Associate Directors (ADs) and Sandra M. Swain, LCCC's clinical network representative. Four Research Programs?Breast Cancer, Cancer Prevention and Control, Experimental Therapeutics and Molecular Oncology?conduct high-impact studies supported by nine Shared Resources. LCCC has 91 members, with a current annual total of $28.7M in peer-reviewed ($18.5M NCI) cancer-focused funding (direct costs), resulting in 1,100 peer-reviewed cancer-related publications from 2009-2012; 32% of which involved intra- and/or interprogrammatic collaborations, and 53% of which involved external collaborations. In 2012, LCCC placed 244 patients on interventional clinical trials (13% of new patients). Notable accomplishments include: 1) discovery of a transformative methodology for epithelial cell reprogramming with rapid translation into clinical trials; 2) development of enabling tools such as novel computational modeling for drug repurposing and integrated informatic platforms; 3) basic discovery (novel mechanisms for genomic instability; transcriptional targeting in Ewing sarcoma; resistance determinants in the EGFR network); 4) leadership of high-impact clinical trials (e.g., evaluation of pertuzumab in breast cancer, role of bendamustine in follicular lymphoma); 5) national collaborative modeling research informing screening mammography guidelines and 6) operational enhancements that include creation of the MedStar Georgetown Cancer Network to expand clinical research in LCCC's catchment area under the direction of recent recruit, Giuseppe Giaccone, MD, PhD (AD, Clinical Research); a reorganization of clinical trial management and regulatory activities to better support the Network; and the continued development of community outreach and research sites in the poorest wards of the District of Columbia.", 
        "endDate": "2019-04-30T00:00:00Z", 
        "funder": {
          "id": "https://www.grid.ac/institutes/grid.48336.3a", 
          "type": "Organization"
        }, 
        "id": "sg:grant.2438858", 
        "identifier": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "2438858"
            ]
          }, 
          {
            "name": "nih_id", 
            "type": "PropertyValue", 
            "value": [
              "P30CA051008"
            ]
          }
        ], 
        "inLanguage": [
          "en"
        ], 
        "keywords": [
          "recent recruits", 
          "compassionate patient care", 
          "MD", 
          "district", 
          "research sites", 
          "partnership", 
          "scientific discovery", 
          "development", 
          "screening mammography guidelines", 
          "cancer", 
          "bendamustine", 
          "reorganization", 
          "patients", 
          "publication", 
          "regulatory activity", 
          "Giuseppe Giaccone", 
          "medical oncologists", 
          "follicular lymphoma", 
          "novel mechanism", 
          "LCCC", 
          "leadership", 
          "mission", 
          "interventional clinical trials", 
          "EGFR network", 
          "external collaboration", 
          "genomic instability", 
          "novel", 
          "MedStar Georgetown Cancer Network", 
          "members", 
          "creation", 
          "experts", 
          "tool", 
          "NCI", 
          "clinical trials", 
          "support", 
          "basic discoveries", 
          "care", 
          "LCCC's clinical network representative", 
          "notable accomplishments", 
          "Director Louis M. Weiner", 
          "national collaborative modeling research", 
          "poorest wards", 
          "rapid translation", 
          "Molecular Oncology?conduct high-impact studies", 
          "high-impact clinical trials", 
          "funding", 
          "transformative methodology", 
          "Columbia", 
          "interprogrammatic collaborations", 
          "PhD", 
          "community", 
          "peer", 
          "direction", 
          "drug repurposing", 
          "community outreach", 
          "Shared Resources", 
          "breast cancer", 
          "transcriptional targeting", 
          "cancer prevention", 
          "immunotherapy expert", 
          "cura personalis", 
          "principle", 
          "computational modeling", 
          "quality education", 
          "pertuzumab", 
          "role", 
          "direct costs", 
          "network", 
          "evaluation", 
          "AD", 
          "Research Programs?Breast Cancer", 
          "operational enhancements", 
          "Sandra M. Swain", 
          "control", 
          "clinical research", 
          "ADs", 
          "clinical trial management", 
          "epithelial cells", 
          "discovery", 
          "Deputy Director Michael B. Atkins", 
          "resistance determinants", 
          "LCCC's catchment area", 
          "Georgetown University Lombardi Cancer Center Support Grant", 
          "current annual total", 
          "whole person", 
          "Experimental Therapeutics", 
          "Ewing's sarcoma", 
          "new patients", 
          "integrated informatic platforms"
        ], 
        "name": "Georgetown University Lombardi Cancer Center Support Grant", 
        "recipient": [
          {
            "id": "https://www.grid.ac/institutes/grid.213910.8", 
            "type": "Organization"
          }, 
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.213910.8", 
              "name": "GEORGETOWN UNIVERSITY", 
              "type": "Organization"
            }, 
            "familyName": "WEINER", 
            "givenName": "LOUIS M.", 
            "id": "sg:person.01127014053.02", 
            "type": "Person"
          }, 
          {
            "member": "sg:person.01127014053.02", 
            "roleName": "PI", 
            "type": "Role"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/details/grant/grant.2438858"
        ], 
        "sdDataset": "grants", 
        "sdDatePublished": "2019-03-07T12:11", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_4.xml.gz", 
        "startDate": "1990-09-30T00:00:00Z", 
        "type": "MonetaryGrant", 
        "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=9483614"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2438858'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2438858'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2438858'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2438858'


     

    This table displays all metadata directly associated to this object as RDF triples.

    133 TRIPLES      19 PREDICATES      110 URIs      102 LITERALS      5 BLANK NODES

    Subject Predicate Object
    1 sg:grant.2438858 schema:about anzsrc-for:2211
    2 schema:amount N00fa2ccf57f1445ea34fd7c812162738
    3 schema:description The mission of the Georgetown Lombardi Comprehensive Cancer Center (LCCC) is to prevent, treat and cure cancers by linking scientific discovery, expert and compassionate patient care, quality education, and partnership with the community, guided by the principle of cura personalis (care for the whole person). LCCC is led by Director Louis M. Weiner, MD, a medical oncologist and immunotherapy expert, with the support of Deputy Director Michael B. Atkins, MD, six Associate Directors (ADs) and Sandra M. Swain, LCCC's clinical network representative. Four Research Programs?Breast Cancer, Cancer Prevention and Control, Experimental Therapeutics and Molecular Oncology?conduct high-impact studies supported by nine Shared Resources. LCCC has 91 members, with a current annual total of $28.7M in peer-reviewed ($18.5M NCI) cancer-focused funding (direct costs), resulting in 1,100 peer-reviewed cancer-related publications from 2009-2012; 32% of which involved intra- and/or interprogrammatic collaborations, and 53% of which involved external collaborations. In 2012, LCCC placed 244 patients on interventional clinical trials (13% of new patients). Notable accomplishments include: 1) discovery of a transformative methodology for epithelial cell reprogramming with rapid translation into clinical trials; 2) development of enabling tools such as novel computational modeling for drug repurposing and integrated informatic platforms; 3) basic discovery (novel mechanisms for genomic instability; transcriptional targeting in Ewing sarcoma; resistance determinants in the EGFR network); 4) leadership of high-impact clinical trials (e.g., evaluation of pertuzumab in breast cancer, role of bendamustine in follicular lymphoma); 5) national collaborative modeling research informing screening mammography guidelines and 6) operational enhancements that include creation of the MedStar Georgetown Cancer Network to expand clinical research in LCCC's catchment area under the direction of recent recruit, Giuseppe Giaccone, MD, PhD (AD, Clinical Research); a reorganization of clinical trial management and regulatory activities to better support the Network; and the continued development of community outreach and research sites in the poorest wards of the District of Columbia.
    4 schema:endDate 2019-04-30T00:00:00Z
    5 schema:funder https://www.grid.ac/institutes/grid.48336.3a
    6 schema:identifier N2ec9b11d0e22405c821dd8fadd57a7bf
    7 N9631db0c5bf84188ab49e28dad697891
    8 schema:inLanguage en
    9 schema:keywords AD
    10 ADs
    11 Columbia
    12 Deputy Director Michael B. Atkins
    13 Director Louis M. Weiner
    14 EGFR network
    15 Ewing's sarcoma
    16 Experimental Therapeutics
    17 Georgetown University Lombardi Cancer Center Support Grant
    18 Giuseppe Giaccone
    19 LCCC
    20 LCCC's catchment area
    21 LCCC's clinical network representative
    22 MD
    23 MedStar Georgetown Cancer Network
    24 Molecular Oncology?conduct high-impact studies
    25 NCI
    26 PhD
    27 Research Programs?Breast Cancer
    28 Sandra M. Swain
    29 Shared Resources
    30 basic discoveries
    31 bendamustine
    32 breast cancer
    33 cancer
    34 cancer prevention
    35 care
    36 clinical research
    37 clinical trial management
    38 clinical trials
    39 community
    40 community outreach
    41 compassionate patient care
    42 computational modeling
    43 control
    44 creation
    45 cura personalis
    46 current annual total
    47 development
    48 direct costs
    49 direction
    50 discovery
    51 district
    52 drug repurposing
    53 epithelial cells
    54 evaluation
    55 experts
    56 external collaboration
    57 follicular lymphoma
    58 funding
    59 genomic instability
    60 high-impact clinical trials
    61 immunotherapy expert
    62 integrated informatic platforms
    63 interprogrammatic collaborations
    64 interventional clinical trials
    65 leadership
    66 medical oncologists
    67 members
    68 mission
    69 national collaborative modeling research
    70 network
    71 new patients
    72 notable accomplishments
    73 novel
    74 novel mechanism
    75 operational enhancements
    76 partnership
    77 patients
    78 peer
    79 pertuzumab
    80 poorest wards
    81 principle
    82 publication
    83 quality education
    84 rapid translation
    85 recent recruits
    86 regulatory activity
    87 reorganization
    88 research sites
    89 resistance determinants
    90 role
    91 scientific discovery
    92 screening mammography guidelines
    93 support
    94 tool
    95 transcriptional targeting
    96 transformative methodology
    97 whole person
    98 schema:name Georgetown University Lombardi Cancer Center Support Grant
    99 schema:recipient N409995043bb9448dbb91844bee6602ba
    100 sg:person.01127014053.02
    101 https://www.grid.ac/institutes/grid.213910.8
    102 schema:sameAs https://app.dimensions.ai/details/grant/grant.2438858
    103 schema:sdDatePublished 2019-03-07T12:11
    104 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    105 schema:sdPublisher Na10720fc564c4981811159319a262b74
    106 schema:startDate 1990-09-30T00:00:00Z
    107 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=9483614
    108 sgo:license sg:explorer/license/
    109 sgo:sdDataset grants
    110 rdf:type schema:MonetaryGrant
    111 N00fa2ccf57f1445ea34fd7c812162738 schema:currency USD
    112 schema:value 49939224
    113 rdf:type schema:MonetaryAmount
    114 N2ec9b11d0e22405c821dd8fadd57a7bf schema:name nih_id
    115 schema:value P30CA051008
    116 rdf:type schema:PropertyValue
    117 N409995043bb9448dbb91844bee6602ba schema:member sg:person.01127014053.02
    118 schema:roleName PI
    119 rdf:type schema:Role
    120 N9631db0c5bf84188ab49e28dad697891 schema:name dimensions_id
    121 schema:value 2438858
    122 rdf:type schema:PropertyValue
    123 Na10720fc564c4981811159319a262b74 schema:name Springer Nature - SN SciGraph project
    124 rdf:type schema:Organization
    125 anzsrc-for:2211 schema:inDefinedTermSet anzsrc-for:
    126 rdf:type schema:DefinedTerm
    127 sg:person.01127014053.02 schema:affiliation https://www.grid.ac/institutes/grid.213910.8
    128 schema:familyName WEINER
    129 schema:givenName LOUIS M.
    130 rdf:type schema:Person
    131 https://www.grid.ac/institutes/grid.213910.8 schema:name GEORGETOWN UNIVERSITY
    132 rdf:type schema:Organization
    133 https://www.grid.ac/institutes/grid.48336.3a schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...